Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study
Mycoses · 2024
DOI: 10.1111/myc.13717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2024. Verfasst von Sabri Atalay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey. Hauptthemen laut MEDLINE: Candidemia, Hypoalbuminemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Candida species are among the most important invasive pathogens in intensive care units (ICUs). Non‐albicans species including Candida parapsilosis ( C. parapsilosis ) has increased in recent years. Fluconazole is the leading antifungal agent but resistance is a concern among C. parapsilosis species.
Objectives
The aim of this study was to determine the factors associated with fluconazole resistance in patients with candidemia due to C. parapsilosis in ICUs.
Methods
This case–case study was conducted in a 750‐bed, tertiary hospital between 2015 and 2021. Patients with fluconazole‐resistant C. parapsilosis candidemia constituted the ‘cases of interest’ group and patients with fluconazole‐susceptible C. parapsilosis candidemia constituted the ‘comparison cases’ group. Demographic and clinical data of the patients were recorded. Logistic regression analysis was performed using the backward elimination method to determine the independent predictors of fluconazole‐resistant C. parapsilosis bloodstream infections.
Results
The study included 177 patients. In the cultures of these patients, 76 (43%) fluconazole‐resistant, 13 (7.3%) fluconazole‐reduced susceptible, and 88 (49.7%) fluconazole‐susceptible isolates were found. In the regression analysis the risk factors for fluconazole‐resistant C. parapsilosis bloodstream infection, malignancy, immunosuppressive treatment, history of intra‐abdominal surgery, hypoalbunemia, previous fluconazole use, and SOFA score were found to be associated in univariate analysis. In multivariate regression analysis, history of intra‐abdominal surgery (OR: 2.16; 95% CI: 1.05–4.44), hypoalbuminemia (OR: 2.56; 95% CI: 1.06–6.17) and previous fluconazole use (OR: 3.35; 95% CI: 1.02–11) were found to be independent predictors.
Conclusions
In this study, a significant correlation was found between candidemia due to fluconazole‐resistant C. parapsilosis in ICUs and intra‐abdominal surgery, hypoalbuminemia, and previous fluconazole use. C. parapsilosis isolates and fluconazole resistance should be continuously monitored, strict infection control measures should be taken and antifungal stewardship programs should be implemented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey.
- Department of Epidemiology, Diyarbakır Provincial Health Directorate, Diyarbakır, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Siirt Training and Research Hospital, Siirt, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Bozyaka Training and Research Hospital, Izmir, Turkey.
- Department of Medical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey.
ORCID-Profile: Sabri Atalay
Zitieren
APA
Atalay, S., Çağlayan, D., Arkalı, E., Sönmez, U., & Şamlıoğlu, P. (2024). Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study. Mycoses. https://doi.org/10.1111/myc.13717
Vancouver
Atalay S, Çağlayan D, Arkalı E, Sönmez U, Şamlıoğlu P. Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study. Mycoses. 2024. doi:10.1111/myc.13717
BibTeX
@article{Atalay2024,
author = {Atalay, Sabri and Çağlayan, Derya and Arkalı, Eren and Sönmez, Ufuk and Şamlıoğlu, Pınar},
title = {Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study},
journal = {Mycoses},
year = {2024},
doi = {10.1111/myc.13717}
}
EUVIMED